Renaissance Technologies LLC Purchases 161,400 Shares of Maximus, Inc. (NYSE:MMS)

Renaissance Technologies LLC lifted its stake in shares of Maximus, Inc. (NYSE:MMS - Free Report) by 66.6% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 403,600 shares of the health services provider's stock after acquiring an additional 161,400 shares during the quarter. Renaissance Technologies LLC owned 0.71% of Maximus worth $30,129,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds have also modified their holdings of MMS. Krane Funds Advisors LLC acquired a new position in Maximus in the fourth quarter valued at approximately $398,000. Invesco Ltd. increased its position in shares of Maximus by 19.6% during the fourth quarter. Invesco Ltd. now owns 250,594 shares of the health services provider's stock worth $18,707,000 after purchasing an additional 41,019 shares in the last quarter. Bank of Montreal Can lifted its holdings in shares of Maximus by 5.4% in the 4th quarter. Bank of Montreal Can now owns 15,863 shares of the health services provider's stock valued at $1,184,000 after purchasing an additional 812 shares during the last quarter. Cerity Partners LLC boosted its position in shares of Maximus by 6.6% in the 4th quarter. Cerity Partners LLC now owns 119,267 shares of the health services provider's stock valued at $8,931,000 after purchasing an additional 7,352 shares during the period. Finally, Aristides Capital LLC increased its position in Maximus by 48.5% during the fourth quarter. Aristides Capital LLC now owns 3,667 shares of the health services provider's stock worth $274,000 after buying an additional 1,197 shares during the period. 97.21% of the stock is currently owned by institutional investors and hedge funds.

Remove Ads

Maximus Price Performance

Shares of Maximus stock traded down $0.56 on Tuesday, hitting $68.18. The company's stock had a trading volume of 324,215 shares, compared to its average volume of 548,788. The company has a quick ratio of 1.72, a current ratio of 1.72 and a debt-to-equity ratio of 0.82. The firm has a fifty day moving average price of $67.71 and a 200-day moving average price of $75.82. Maximus, Inc. has a 52-week low of $63.77 and a 52-week high of $93.97. The company has a market capitalization of $3.86 billion, a P/E ratio of 14.66 and a beta of 0.68.

Maximus (NYSE:MMS - Get Free Report) last issued its quarterly earnings data on Thursday, February 6th. The health services provider reported $1.61 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.39 by $0.22. Maximus had a return on equity of 21.95% and a net margin of 5.28%. On average, equities research analysts expect that Maximus, Inc. will post 6.15 earnings per share for the current fiscal year.

Maximus Dividend Announcement

The company also recently disclosed a quarterly dividend, which will be paid on Saturday, May 31st. Investors of record on Thursday, May 15th will be given a $0.30 dividend. The ex-dividend date of this dividend is Thursday, May 15th. This represents a $1.20 annualized dividend and a yield of 1.76%. Maximus's dividend payout ratio is presently 25.81%.

Wall Street Analysts Forecast Growth

MMS has been the topic of a number of research reports. StockNews.com lowered shares of Maximus from a "buy" rating to a "hold" rating in a research report on Friday, February 14th. Raymond James upgraded shares of Maximus from a "market perform" rating to an "outperform" rating and set a $90.00 price objective for the company in a research report on Thursday, January 2nd.

Insiders Place Their Bets

In other news, insider Ilene R. Baylinson sold 14,500 shares of the company's stock in a transaction on Wednesday, February 19th. The stock was sold at an average price of $68.14, for a total value of $988,030.00. Following the completion of the sale, the insider now owns 2,512 shares in the company, valued at $171,167.68. This represents a 85.23 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link. Also, Director Jan Madsen sold 2,439 shares of Maximus stock in a transaction that occurred on Tuesday, March 18th. The stock was sold at an average price of $67.71, for a total transaction of $165,144.69. Following the completion of the transaction, the director now owns 18,097 shares in the company, valued at approximately $1,225,347.87. This trade represents a 11.88 % decrease in their position. The disclosure for this sale can be found here. 1.60% of the stock is owned by insiders.

Maximus Profile

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.